<DOC>
	<DOCNO>NCT01953731</DOCNO>
	<brief_summary>This study compare plasma pharmacokinetics single 125mg oral dose palbociclib presence absence rifampin-mediated enzyme induction fixed-sequence two-period study .</brief_summary>
	<brief_title>A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib ( PD-0332991 )</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male female nonchildbearing potential body mass index 17.530.5 kg/m2 total body weight great 50kg Evidence history clinically significant physiologic , psychological , medical condition positive drug screen alcohol breath test baseline ECG demonstrate QTc &gt; 450msecs QRS interval &gt; 120msecs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>palbociclib</keyword>
	<keyword>PD-0332991</keyword>
	<keyword>rifampin</keyword>
	<keyword>drug-drug interaction study</keyword>
</DOC>